Baozun to Announce First Quarter 2026 Unaudited Financial Results on May 20, 2026
SHANGHAI, May 8, 2026 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a...
Read moreDetails
Press Releases
Online Lender Loanz Doubles Down on Canada Following Strategic Restructure Driven by Consumer Demand and Market Conditions
Responding to shifting consumer demand and a challenging US lending environment, Loanz has strategically realigned its operations toward Canada, relaunching...
Read moreDetailsPan African Resources Plc – Update on proposed acquisition of Emmerson Resources
Pan African Resources PLC (Incorporated and registered in England and Wales under the Companies Act 1985 with registered number 3937466...
Read moreDetailsMINISFORUM and Intel to Unveil a New Chapter of Agent NAS
XIAMEN, China, May 8, 2026 /PRNewswire/ -- MINISFORUM and Intel officially hosted a joint launch event in Xiamen under the theme...
Read moreDetails
BioQ Debuts at in‑cosmetics Global, Showcasing China’s Advancing Strength in Ingredient Innovation
PARIS, May 8, 2026 /PRNewswire/ -- BioQ, the biotechnology affiliate of Chinese skincare brand GUYU, made its first appearance as...
Read moreDetailsHexagon Composites ASA: Ex. date for potential subsequent offering
OSLO, Norway, May 8, 2026 /PRNewswire/ -- Reference is made to the stock exchange announcement made by Hexagon Composites ASA (the...
Read moreDetailsBest Accounting Software for Growing Business UK (2026): QuickBooks Named Top Financial Management Platform for UK Growing Businesses by Software Experts
NEW YORK, May 8, 2026 /PRNewswire/ -- As UK businesses continue to scale in a more complex economic environment, demand is...
Read moreDetailsHarbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 8, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company...
Read moreDetailsThe 23rd World Congress on Breast Cancer and Breast Healthcare to Be Held in Tianjin
TIANJIN, China, May 8, 2026 /PRNewswire/ -- To further promote academic exchange and practical collaboration in the global field of...
Read moreDetailsOblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
GOTHENBURG, Sweden, May 8, 2026 /PRNewswire/ -- The recruitment represents a significant strategic addition to the company as it continues...
Read moreDetails